Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (NASDAQ: HZNP): NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR…
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (NASDAQ: HZNP): NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR…
Clear Junction announces the launch of its new escrow account solution The escrow accounts will…
Inventiva intends to use the proceeds to fund part of the pivotal Phase III clinical…
Today, Novozymes and Chr. Hansen have entered into an agreement to create a leading global…
Tetris Pharma signs service agreement with Syneos Health Partnership to support Tetris Pharma roll-out of…
Internet City, Dubai–(Newsfile Corp. – December 12, 2022) – LBank Exchange, a global digital asset…
Arasat Al Hindi, Iraq–(Newsfile Corp. – December 12, 2022) – First Iraqi Bank has officially…
Internet City, Dubai–(Newsfile Corp. – December 12, 2022) – LBank Exchange, a global digital asset…
Pulsed power could transform mining and decarbonise key steps of the mineral extraction process BHP…
Seattle, Washington–(Newsfile Corp. – December 12, 2022) – Lithosphere developer KaJ Labs has announced that…
TOKYO, Dec 12, 2022 – (JCN Newswire) – ROOKIE Racing Co., Ltd. (ROOKIE Racing) and…
SINGAPORE, Dec 12, 2022 – (ACN Newswire) – Society Pass Incorporated (“SoPa”) (Nasdaq: SOPA), Southeast…
Adopting a new SaaS model, Jet Analytics Cloud is delivered via Microsoft Azure to provide…
TOKYO–(BUSINESS WIRE)–#2022GSAawards–Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced…
SAN DIEGO–(BUSINESS WIRE)–$GNRC #GNRC—The Class: Robbins LLP reminds investors that a shareholder filed a class…
TOKYO, Dec 12, 2022 – (JCN Newswire) – Fujitsu today announced that it joined a…
– Data Suggest Long-term Treatment with PYRUKYND® in Adults with PK Deficiency is Associated with…
HONG KONG, Dec 12, 2022 – (ACN Newswire) – InvesTech Holdings Limited (“InvesTech Holdings”; together…
– 89% ORR in TKI-therapy naïve patients; 73% ORR in all evaluable patients with 27-week…
Transplanted hypoimmune (HIP)-modified allogeneic CD19-targeted CAR T cells control CD19+ tumor cells in fully immunocompetent…